WT1 epitope-specific IgG and IgM antibodies for immune-monitoring in patients with advanced sarcoma treated with a WT1 peptide cancer vaccine

The Wilms' tumor gene WT1 is highly expressed in various malignancies and may be a common target antigen for cancer immunotherapy. In our group, peptide-based cancer vaccines targeting WT1 CTL epitopes were developed as an immunotherapy for these malignancies. In the present study, WT1 epitope-...

Descripción completa

Detalles Bibliográficos
Autores principales: Alzaaqi, Shouq, Naka, Norifumi, Hamada, Kenichiro, Hosen, Naoki, Kanegae, Mizuki, Outani, Hidetatsu, Adachi, Mayuko, Imanishi, Rin, Morii, Eiichi, Iwai, Miki, Nakata, Jun, Fujiki, Fumihiro, Morimoto, Soyoko, Nakajima, Hiroko, Nishida, Sumiyuki, Tsuboi, Akihiro, Oka, Yoshihiro, Sugiyama, Haruo, Oji, Yusuke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8756391/
https://www.ncbi.nlm.nih.gov/pubmed/35069874
http://dx.doi.org/10.3892/ol.2022.13184

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8756391/
https://www.ncbi.nlm.nih.gov/pubmed/35069874
http://dx.doi.org/10.3892/ol.2022.13184

Ejemplares similares